SCHEMBL28624731

SCHEMBL28624731

CC(C)(C)OC(=O)N1CC(N2CCC(c3ccc(-n4cc5cccc(C(N)=O)c5n4)cc3)CC2)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 0.59
PARP2 Q9UGN5 12/20 0.54
PARP3 Q9Y6F1 12/20 0.54
TNKS O95271 1/20 0.54
CHRM2 P08172 1/20 0.54
CHRM1 P11229 1/20 0.54
SLC6A2 P23975 1/20 0.54
SLC6A4 P31645 1/20 0.54
ADRA1A P35348 1/20 0.54
SLC6A3 Q01959 1/20 0.54
KCNH2 Q12809 1/20 0.54
DYRK1A Q13627 1/20 0.54
PARP15 Q460N3 1/20 0.54
PARP14 Q460N5 1/20 0.54
PARP10 Q53GL7 1/20 0.54
PARP12 Q9H0J9 1/20 0.54
TNKS2 Q9H2K2 1/20 0.54
PARP4 Q9UKK3 1/20 0.54
DYRK1B Q9Y463 1/20 0.54
HRH3 Q9Y5N1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28627270 0.93 PARP1 (0.59) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL28612811 0.91 PARP1 (0.65) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL1421856 0.87 PARP1 (0.61) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL23854758 0.87 PARP1 (0.61) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL28618123 0.82 PARP1 (0.83) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL28629351 0.82 PARP1 (0.69) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL28614035 0.82 PARP1 (0.52) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL28624105 0.81 PARP1 (0.74) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL5016308 0.79 PARP1 (0.61) PARP1PARP2PARP3TNKSCHRM2
SCHEMBL1421860 0.79 PARP1 (0.61) PARP1PARP2PARP3TNKSCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113292536-A Compound capable of degrading Bcr-Abl or PARP and preparation method and pharmaceutical application thereof 四川海思科制药有限公司 2021-08-24 CN disclosed